Ivermectin and gynecologic cancer: what's the data?
Gynaecological oncologists reviewed the evidence for ivermectin in womb, ovarian and cervical cancers, found only cell-line data, and strongly caution against using it.
Overview
The review states that ivermectin was approved by the FDA in 1996 as an oral medicine for intestinal strongyloidiasis and onchocerciasis, that data on it as a gynaecological cancer-fighting compound are lacking, and that clinical studies of ivermectin in cancer are limited to effects observed in cell lines (Mujumdar review 2025). Its authors write that they have not assessed its safety and efficacy in gynaecological cancers and 'do not recommend and strongly caution' its use (Mujumdar review 2025).
- Clinical evidence for ivermectin in gynaecological cancers is limited to cell-line studies.
- The authors strongly caution against its use for these cancers.
For a patient with a gynaecological cancer, the specialists who would run such a trial say the evidence does not exist yet.
- Review of a field with almost no clinical data; the conclusion rests on absence of evidence rather than on trials showing harm.
Similar pages
not linked directly; found by shared links- Key paperMetastatic melanoma with initial ctDNA decline and radiographic response during self-directed antiparasitic use: treatment effect or spontaneous regression?
Shares Fenbendazole, ivermectin and other internet 'repurposed cures', Ivermectin.
- TrialAtavistic chemotherapy: combinations of antibacterial, antifungal and antiprotozoal drugs in advanced cancer (Arguello clinic, status unknown)
Shares Fenbendazole, ivermectin and other internet 'repurposed cures', Ivermectin.
- Key paperCancer therapy using antiparasitic medications guided by acupuncture meridian assessment: a case series of six patients
Shares Fenbendazole, ivermectin and other internet 'repurposed cures', Ivermectin.
- Key paperIvermectin treatment for gynecologic cancers: hope versus hype
Shares Fenbendazole, ivermectin and other internet 'repurposed cures', Ivermectin.
- Key paperIvermectin-benzimidazole prescribing following celebrity endorsement
Shares Fenbendazole, ivermectin and other internet 'repurposed cures', Ivermectin.
- Key paperThe multitargeted drug ivermectin: from an antiparasitic agent to a repositioned cancer drug
Shares Fenbendazole, ivermectin and other internet 'repurposed cures', Ivermectin.
- Key paperIvermectin in cancer treatment: should healthcare providers caution or explore its therapeutic potential?
Shares Fenbendazole, ivermectin and other internet 'repurposed cures', Ivermectin.
- Key paperReal-world clinical outcomes of ivermectin and mebendazole in cancer patients: results from a prospective observational cohort (with 2026 expression of concern)
Shares Fenbendazole, ivermectin and other internet 'repurposed cures', Ivermectin.